Ropinirole for restless legs syndrome
| Autor: | J. G. Hentz, John N. Caviness, W. M. Anderson, L. Marlor, Kapil D. Sethi, Robert A. Hauser, Charles H. Adler |
|---|---|
| Rok vydání: | 2004 |
| Předmět: |
Adult
Male Indoles Nausea Neurological disorder Placebo Dizziness law.invention Double-Blind Method Randomized controlled trial law Restless Legs Syndrome mental disorders medicine Humans Restless legs syndrome Adverse effect Aged Aged 80 and over Cross-Over Studies Dose-Response Relationship Drug Middle Aged medicine.disease Crossover study Treatment Outcome Ropinirole Anesthesia Dopamine Agonists Female Neurology (clinical) medicine.symptom Psychology medicine.drug |
| Zdroj: | Neurology. 62:1405-1407 |
| ISSN: | 1526-632X 0028-3878 |
| Popis: | The authors performed a double-blind, placebo-controlled, crossover study of ropinirole (0.5 to 6.0 mg/day) for restless legs syndrome (RLS). The RLS Rating Scale score improved (p < 0.001) from a mean (SD) of 25 (7) during placebo treatment to 13 (12) during ropinirole treatment. Eight of the 22 patients had complete resolution of symptoms on ropinirole. Adverse events included nausea and dizziness. Ropinirole was effective and well tolerated for treating the symptoms of RLS. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|